These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8344170)
1. [Coagulation parameters in high-dosage intravenous heparin therapy]. Hafner G Dtsch Med Wochenschr; 1993 Aug; 118(31):1131-2. PubMed ID: 8344170 [No Abstract] [Full Text] [Related]
2. [Monitoring of heparin therapy using thrombin time and activated partial thromboplastin time--a comparison]. Osterwalder J Schweiz Med Wochenschr; 1987 Apr; 117(14):539-40. PubMed ID: 3576165 [No Abstract] [Full Text] [Related]
3. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time]. Lutze G; Presser HJ; Urbahn H Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657 [TBL] [Abstract][Full Text] [Related]
4. Thrombin time dilution test: a simple method for the control of heparin therapy. Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933 [No Abstract] [Full Text] [Related]
6. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring]. Domula M; Weissbach G Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049 [TBL] [Abstract][Full Text] [Related]
7. The monitoring of heparin administration by screening tests in experimental dogs. Mischke R; Jacobs C Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088 [TBL] [Abstract][Full Text] [Related]
8. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. Ray PK; Harper TA J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859 [No Abstract] [Full Text] [Related]
9. [Heparin therapy and its monitoring]. Camici M; Evangelisti L Clin Ter; 1991 Feb; 136(4):279-82. PubMed ID: 1827391 [No Abstract] [Full Text] [Related]
10. Heparin: clinical or distributive problem? Vogenberg FR; Mantel SA Am J Hosp Pharm; 1982 Nov; 39(11):1854, 1856. PubMed ID: 7148849 [No Abstract] [Full Text] [Related]
15. [The coagulation parameters in high-dosage intravenous heparin therapy]. Weidmann B Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564 [No Abstract] [Full Text] [Related]
16. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy. Bremme K; Lind H; Blombäck M Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465 [TBL] [Abstract][Full Text] [Related]
17. Heparin assay methods for control of in vivo heparin effects. Godal HC Thromb Diath Haemorrh; 1975 Feb; 33(1):77-80. PubMed ID: 1091021 [No Abstract] [Full Text] [Related]